Search Results 311-320 of 9839 for 搜索引擎推荐咨询邮箱:lgooxc@hotmail.com
About this study. Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect ...
Contact. Hari Chaliki, M.D.. Program Director. Kaitlyn Robison Education Coordinator Phone: 480-574-2151. Email: robison.kaitlyn@ ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.
About this study. This study will evaluate the impact of a proactive, EHR-supported enrollment strategy that links LDCT-eligible smokers with an ...
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...
About this study. The primary purpose of this study is to evaluate the incremental invasive cancer yield in patients with a negative mammogram who are ...
About this study. The purpose of this study is to evaluate the safety and efficacy of I-DXd in combination with immune checkpoint inhibitor atezolizumab ...
CME Accreditation. Accreditation statement. Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to ...
Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.